- Business
- Glanbia plc is a global nutrition company headquartered in Kilkenny, Ireland, and founded in 1997 through the merger of Avonmore and Waterford cooperatives. The company operates primarily through three divisions--Glanbia Nutritionals, Glanbia Performance Nutrition, and Joint Ventures--focusing on dairy-based nutritional ingredients and consumer sports nutrition products; its core offerings include whey protein concentrates and isolates, nutritional premixes, flavor systems, custom dairy blends, cheese and non-dairy proteins, vitamin and mineral premixes, as well as branded performance nutrition products such as Optimum Nutrition protein powders, Isopure zero-carb proteins, thinkThin and Quest protein bars, SlimFast meal replacements, and BSN supplements sold in powder, ready-to-drink, and bar formats. Glanbia Nutritionals supplies functional ingredients to food, beverage, and pharmaceutical manufacturers worldwide, while Glanbia Performance Nutrition targets athletes, health-conscious consumers, and lifestyle markets via retail, e-commerce, gyms, and foodservice channels; the company serves over 130 countries with major operations in North America, Europe, Asia-Pacific, Latin America, and the Middle East, including manufacturing facilities in the US, Ireland, UK, Germany, and China. In recent developments, Glanbia completed the 2024 acquisition of Flavor Producers LLC for an initial $300 million plus up to $55 million in deferred consideration to bolster its natural and organic flavors platform within Glanbia Nutritionals; the company also announced in late 2024 a restructuring of its Nutritionals business effective 2025 into separate Health and Nutrition and Dairy Nutrition segments, alongside ongoing share buyback programs totaling €150 million including a new €50 million tranche starting early 2025. Glanbia continues to divest non-core assets, such as its 2022 sale of the 40% stake in Glanbia Ireland (now Tirlán), to sharpen focus on global nutrition solutions amid strong revenue growth exceeding €3.5 billion annually from high-demand health and wellness categories.